Publikationen, an denen er mitarbeitet María Dolores Tabernero (61)

2024

  1. Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome

    Biology, Vol. 13, Núm. 5

2023

  1. Clinical, Histopathologic and Genetic Features of Rhabdoid Meningiomas

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2021

  1. Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome

    Brain Pathology, Vol. 31, Núm. 2, pp. 365-380

  2. Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas

    Frontiers in Oncology, Vol. 11

2020

  1. Heterogeneous EGFR, CDK4, MDM4, and PDGFRA gene expression profiles in primary GBM: No association with patient survival

    Cancers, Vol. 12, Núm. 1

  2. Multivariate analysis reveals differentially expressed genes among distinct subtypes of diffuse astrocytic gliomas: diagnostic implications

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles

    Oncotarget, Vol. 9, Núm. 46, pp. 28083-28102

2017

  1. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK

    Stem Cell Reports, Vol. 9, Núm. 2, pp. 451-463

2016

  1. Re-Evaluating Simpson Grade I, II, and III Resections in Neurosurgical Treatment of World Health Organization Grade I Meningiomas

    World Neurosurgery, Vol. 96, pp. 483-488

  2. Tumor infiltrating immune cells in gliomas and meningiomas

    Brain, Behavior, and Immunity, Vol. 53, pp. 1-15

2015

  1. Genetic/molecular alterations of meningiomas and the signaling pathways targeted

    Oncotarget, Vol. 6, Núm. 13, pp. 10671-10688

  2. Molecular and Genomic Alterations in Glioblastoma Multiforme

    American Journal of Pathology, Vol. 185, Núm. 7, pp. 1820-1833

  3. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: A surrogate marker for NK-cell clonality

    Oncotarget, Vol. 6, Núm. 40, pp. 42938-42951

  4. The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 3, pp. 319-332

2014

  1. Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype

    Neuro-Oncology, Vol. 16, Núm. 5, pp. 735-747

2013

  1. Association between Inflammatory Infiltrates and Isolated Monosomy 22/del(22q) in Meningiomas

    PLoS ONE, Vol. 8, Núm. 10

  2. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas

    BMC Medical Genetics, Vol. 14, Núm. 1

  3. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: A study in highly purified aberrant plasma cells

    Haematologica, Vol. 98, Núm. 2, pp. 279-287

2012

  1. Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels

    PLoS ONE, Vol. 7, Núm. 9

  2. Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays

    Genes Chromosomes and Cancer, Vol. 51, Núm. 6, pp. 606-617